AstraZeneca NDC 0310-0272-10 100 tablets SeroQUEL (quetiapine) tablets 200 mg* Rx only Medication Guide must be dispensed to patients
Among this patient population, 4,321 people took semaglutide the active ingredient in Ozempic and Wegovy and 2,509 used liraglutide, an older GLP-1 drug
While your body naturally produces peptides, production decreases with age , which can lead to: Slower metabolism and weight gain Decreased muscle mass and energy Slower healing and recovery Visible signs of aging like wrinkles and sagging skin Through targeted therapy, we can restore and boost peptide levels, helping your body perform optimally again
Most are expected to follow CVS Caremark (covering Wegovy) Some may have different PA requirements Check with HR during open enrollment for any changes Medicare/Medicaid Policy Changes Medicare Part D policy changes are expected mid-2026 that could expand GLP-1 coverage
Overall, at baseline, 26.9% of patients did not have established cardiovascular (CV) disease, while 73.1% had established CV disease
It occurs especially during the decades from 30 to 50, but may be seen in any age group, including children
